Volume 42, Issue 6 pp. 605-610
Concise Report

Synthesis of Anti-Pancreatic Cancer Natural Product Majusculamide D and Analogues Reveals a Preliminary Structure-Activity Relationships

Xiuhe Zhao

Xiuhe Zhao

The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin, 300350 China

Search for more papers by this author
Mengxue Lv

Mengxue Lv

The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin, 300350 China

Search for more papers by this author
Xiaonan Xi

Xiaonan Xi

The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin, 300350 China

Search for more papers by this author
Yaxin Lu

Yaxin Lu

College of Chemistry, Nankai University, Tianjin, 300071 China

Search for more papers by this author
Liang Wang

Corresponding Author

Liang Wang

College of Chemistry, Nankai University, Tianjin, 300071 China

E-mail: [email protected]; [email protected]Search for more papers by this author
Yue Chen

Corresponding Author

Yue Chen

College of Chemistry, Nankai University, Tianjin, 300071 China

E-mail: [email protected]; [email protected]Search for more papers by this author
First published: 13 November 2023

Comprehensive Summary

The total synthesis of majusculamide D (1) was achieved from commercially available materials. In addition, we synthesized eight analogues including three stereoisomers of majusculamide D that differ in the fatty acid chain. Six analogues including a simplified analogue 29 exhibited significant nanomolar-level IC50 values against Panc-1 cells in MTT assays. A preliminary SAR analysis indicated that the hydroxyl group at C10 and C2−C3 unsaturated double bond of majusculamide D were essential in maintaining the high activity against Panc-1 cells and the orientation of C40-Me and C42-Me groups was tolerable.image

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.